<?xml version="1.0" encoding="UTF-8"?>
<html xmlns="http://www.w3.org/1999/xhtml">
 <head charset="UTF-8"/>
 <style> * { font-family : helvetica;} .font17 { font-size : 17; } .font18 { font-size : 18; } .font10 { font-size : 10; } .font11 { font-size : 11; } .font28 { font-size : 28; } .font12 { font-size : 12; } .font13 { font-size : 13; } .font30 { font-size : 30; } .font14 { font-size : 14; } .font15 { font-size : 15; }</style>
 <body>
  <p>
   <span class="font30">the </span>
   <span class="font28">and </span>
   <span class="font18">with </span>
   <span class="font17">for </span>
   <span class="font15">patients </span>
   <span class="font14">COVID- </span>
   <span class="font14">was </span>
   <span class="font14">treatment </span>
   <span class="font13">that </span>
   <span class="font13">SARS-CoV- </span>
   <span class="font13">{background </span>
   <span class="font13">coronavirus </span>
   <span class="font13">viral </span>
   <span class="font13">respiratory </span>
   <span class="font12">against </span>
   <span class="font12">infection </span>
   <span class="font12">clinical </span>
   <span class="font12">efficacy </span>
   <span class="font12">margin </span>
   <span class="font12">remdesivir </span>
   <span class="font12">The </span>
   <span class="font12">{border-style </span>
   <span class="font12">px;} </span>
   <span class="font12">virus </span>
   <span class="font12">#ffffff;} </span>
   <span class="font12">from </span>
   <span class="font12">severe </span>
   <span class="font12">are </span>
   <span class="font12">disease </span>
   <span class="font12">potential </span>
   <span class="font11">day </span>
   <span class="font11">shown </span>
   <span class="font11">Mar </span>
   <span class="font11">also </span>
   <span class="font11">among </span>
   <span class="font11">antiviral </span>
   <span class="font11">have </span>
   <span class="font11">were </span>
   <span class="font11">SARS-CoV </span>
   <span class="font11">acute </span>
   <span class="font11">al. </span>
   <span class="font11">hydroxychloroquine </span>
   <span class="font11">syndrome </span>
   <span class="font11">RNA </span>
   <span class="font11">than </span>
   <span class="font11">MERS-CoV </span>
   <span class="font11">Med </span>
   <span class="font11">activity </span>
   <span class="font11">human </span>
   <span class="font11">novel </span>
   <span class="font11">Ebola </span>
   <span class="font11">Infect </span>
   <span class="font11">agents </span>
   <span class="font11">favipiravir </span>
   <span class="font11">inhibitor </span>
   <span class="font11">inhibitors </span>
   <span class="font11">plasma </span>
   <span class="font11">promising </span>
   <span class="font11">protease </span>
   <span class="font11">therapy </span>
   <span class="font11">Chinese </span>
   <span class="font11">Microbiol </span>
   <span class="font11">azithromycin </span>
   <span class="font11">been </span>
   <span class="font11">critically </span>
   <span class="font11">days </span>
   <span class="font11">drug </span>
   <span class="font11">has </span>
   <span class="font11">ill </span>
   <span class="font11">influenza </span>
   <span class="font11">its </span>
   <span class="font11">might </span>
   <span class="font11">patients. </span>
   <span class="font11">px; </span>
   <span class="font11">therapeutic </span>
   <span class="font11">vitro </span>
   <span class="font11">{font-family </span>
   <span class="font10">Feb </span>
   <span class="font10">However, </span>
   <span class="font10">Immunol </span>
   <span class="font10">SARS </span>
   <span class="font10">cells </span>
   <span class="font10">chloroquine </span>
   <span class="font10">combination </span>
   <span class="font10">drugs </span>
   <span class="font10">font-size </span>
   <span class="font10">host </span>
   <span class="font10">including </span>
   <span class="font10">observed </span>
   <span class="font10">other </span>
   <span class="font10">polymerase </span>
   <span class="font10">such </span>
   <span class="font10">this </span>
   <span class="font10">used </span>
   <span class="font10">ACE </span>
   <span class="font10">Dis </span>
   <span class="font10">Inhibition </span>
   <span class="font10">LPV/RTV </span>
   <span class="font10">Wuhan, </span>
   <span class="font10">active </span>
   <span class="font10">antibodies </span>
   <span class="font10">antibody </span>
   <span class="font10">cases </span>
   <span class="font10">cathepsin </span>
   <span class="font10">double; </span>
   <span class="font10">early </span>
   <span class="font10">effective </span>
   <span class="font10">infection. </span>
   <span class="font10">inhibit </span>
   <span class="font10">load </span>
   <span class="font10">lower </span>
   <span class="font10">model </span>
   <span class="font10">not </span>
   <span class="font10">outbreak </span>
   <span class="font10">plus </span>
   <span class="font10">pneumonia </span>
   <span class="font10">polyclonal </span>
   <span class="font10">prevention </span>
   <span class="font10">protein </span>
   <span class="font10">reported </span>
   <span class="font10">some </span>
   <span class="font10">use </span>
   <span class="font10">well </span>
   <span class="font10">(COVID-) </span>
   <span class="font10">Additionally, </span>
   <span class="font10">Elsevier </span>
   <span class="font10">Engl </span>
   <span class="font10">Taiwan </span>
   <span class="font10">administered </span>
   <span class="font10">after </span>
   <span class="font10">anti-SARS-CoV- </span>
   <span class="font10">being </span>
   <span class="font10">border-color </span>
   <span class="font10">border-width </span>
   <span class="font10">cell </span>
   <span class="font10">convalescent </span>
   <span class="font10">daily </span>
   <span class="font10">distress </span>
   <span class="font10">endosomal </span>
   <span class="font10">evidence </span>
   <span class="font10">high </span>
   <span class="font10">important </span>
   <span class="font10">inhibits </span>
   <span class="font10">most </span>
   <span class="font10">research </span>
   <span class="font10">rhesus </span>
   <span class="font10">solid; </span>
   <span class="font10">spike </span>
   <span class="font10">studyLancet </span>
   <span class="font10">target </span>
   <span class="font10">teicoplanin </span>
   <span class="font10">tract </span>
   <span class="font10">treating </span>
   <span class="font10">twice </span>
   <span class="font10">viruses </span>
   <span class="font10">within </span>
   <span class="font10">{font-style </span>
   <span class="font10">{font-weight </span>
   <span class="font10">(e.g., </span>
   <span class="font10">Agents </span>
   <span class="font10">COVID-. </span>
   <span class="font10">COVID-: </span>
   <span class="font10">Care </span>
   <span class="font10">China </span>
   <span class="font10">China: </span>
   <span class="font10">Despite </span>
   <span class="font10">RNA-dependent </span>
   <span class="font10">Remdesivir </span>
   <span class="font10">Res </span>
   <span class="font10">addition, </span>
   <span class="font10">administration </span>
   <span class="font10">adults </span>
   <span class="font10">ahead </span>
   <span class="font10">alternative </span>
   <span class="font10">anti-inflammatory </span>
   <span class="font10">associated </span>
   <span class="font10">bold </span>
   <span class="font10">caused </span>
   <span class="font10">centre </span>
   <span class="font10">children </span>
   <span class="font10">concentration </span>
   <span class="font10">control </span>
   <span class="font10">courier; </span>
   <span class="font10">demonstrated </span>
   <span class="font10">effect </span>
   <span class="font10">em; </span>
   <span class="font10">entry </span>
   <span class="font10">enzyme </span>
   <span class="font10">followed </span>
   <span class="font10">good </span>
   <span class="font10">into </span>
   <span class="font10">late </span>
   <span class="font10">monoclonal </span>
   <span class="font10">mouse </span>
   <span class="font10">note, </span>
   <span class="font10">once </span>
   <span class="font10">potency </span>
   <span class="font10">print] </span>
   <span class="font10">progression </span>
   <span class="font10">prophylactic </span>
   <span class="font10">pt;} </span>
   <span class="font10">receptor </span>
   <span class="font10">regimen </span>
   <span class="font10">resource </span>
   <span class="font10">ribavirin </span>
   <span class="font10">safety </span>
   <span class="font10">studies </span>
   <span class="font10">suggested </span>
   <span class="font10">targets </span>
   <span class="font10">tissue </span>
   <span class="font10">trial </span>
   <span class="font10">viruses. </span>
   <span class="font10">which </span>
   <span class="font10">who </span>
   <span class="font10">zoonotic </span>
  </p>
 </body>
</html>
